Los Angeles Capital Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.03M | Buy |
24,000
+22,799
| +1,898% | +$7.49M | 0.03% | 290 |
|
|
2025
Q4 | $387K | Sell |
1,201
-50
| -4% | -$16.9K | ﹤0.01% | 995 |
|
|
2025
Q3 | $404K | Sell |
1,251
-3,905
| -76% | -$1.21M | ﹤0.01% | 1006 |
|
|
2025
Q2 | $2.01M | Buy |
5,156
+4,022
| +355% | +$1.62M | 0.01% | 460 |
|
|
2025
Q1 | $493K | Sell |
1,134
-29
| -2% | -$11.6K | ﹤0.01% | 747 |
|
|
2024
Q4 | $429K | Sell |
1,163
-2,998
| -72% | -$1.25M | ﹤0.01% | 846 |
|
|
2024
Q3 | $2.16M | Sell |
4,161
-86,628
| -95% | -$46.3M | 0.01% | 441 |
|
|
2024
Q2 | $49.2M | Sell |
90,789
-54,811
| -38% | -$29M | 0.18% | 109 |
|
|
2024
Q1 | $75.5M | Sell |
145,600
-27,210
| -16% | -$13.5M | 0.26% | 87 |
|
|
2023
Q4 | $81.5M | Buy |
172,810
+88,546
| +105% | +$40.9M | 0.3% | 76 |
|
|
2023
Q3 | $36.7M | Sell |
84,264
-3,111
| -4% | -$1.41M | 0.16% | 126 |
|
|
2023
Q2 | $38.8M | Sell |
87,375
-338
| -0.4% | -$156K | 0.16% | 126 |
|
|
2023
Q1 | $40.3M | Sell |
87,713
-31,253
| -26% | -$14.9M | 0.18% | 129 |
|
|
2022
Q4 | $61M | Buy |
118,966
+32,114
| +37% | +$16.3M | 0.3% | 84 |
|
|
2022
Q3 | $39.5M | Sell |
86,852
-2,805
| -3% | -$1.34M | 0.2% | 119 |
|
|
2022
Q2 | $43.3M | Sell |
89,657
-3,850
| -4% | -$1.9M | 0.21% | 103 |
|
|
2022
Q1 | $45.9M | Buy |
93,507
+1,944
| +2% | +$889K | 0.18% | 111 |
|
|
2021
Q4 | $42.4M | Sell |
91,563
-5,803
| -6% | -$2.44M | 0.16% | 124 |
|
|
2021
Q3 | $36.3M | Sell |
97,366
-142,182
| -59% | -$54M | 0.17% | 121 |
|
|
2021
Q2 | $91.5M | Sell |
239,548
-16,513
| -6% | -$6.31M | 0.4% | 59 |
|
|
2021
Q1 | $91.9M | Buy |
256,061
+106,231
| +71% | +$34.2M | 0.42% | 55 |
|
|
2020
Q4 | $48.1M | Sell |
149,830
-114,187
| -43% | -$35M | 0.21% | 102 |
|
|
2020
Q3 | $70.9M | Buy |
264,017
+25,856
| +11% | +$6.96M | 0.33% | 65 |
|
|
2020
Q2 | $62.6M | Buy |
238,161
+21,931
| +10% | +$5.85M | 0.3% | 79 |
|
|
2020
Q1 | $49.1M | Buy |
216,230
+23,363
| +12% | +$6.37M | 0.31% | 80 |
|
|
2019
Q4 | $58.3M | Buy |
192,867
+26,407
| +16% | +$7.27M | 0.29% | 90 |
|
|
2019
Q3 | $40M | Buy |
166,460
+32,525
| +24% | +$8.91M | 0.22% | 115 |
|
|
2019
Q2 | $37.8M | Sell |
133,935
-10,063
| -7% | -$2.75M | 0.2% | 113 |
|
|
2019
Q1 | $41.3M | Sell |
143,998
-111,598
| -44% | -$32.3M | 0.23% | 107 |
|
|
2018
Q4 | $67.1M | Sell |
255,596
-49,744
| -16% | -$13.7M | 0.42% | 62 |
|
|
2018
Q3 | $83.7M | Buy |
305,340
+9,490
| +3% | +$2.46M | 0.44% | 44 |
|
|
2018
Q2 | $70.4M | Sell |
295,850
-721
| -0.2% | -$167K | 0.39% | 44 |
|
|
2018
Q1 | $65.2M | Buy |
296,571
+4,818
| +2% | +$1.13M | 0.37% | 59 |
|
|
2017
Q4 | $65.6M | Sell |
291,753
-60,585
| -17% | -$12.9M | 0.36% | 66 |
|
|
2017
Q3 | $66.9M | Buy |
352,338
+365
| +0.1% | +$69.5K | 0.39% | 61 |
|
|
2017
Q2 | $66.2M | Sell |
351,973
-100
| -0% | -$18K | 0.42% | 47 |
|
|
2017
Q1 | $58.2M | Sell |
352,073
-5,773
| -2% | -$918K | 0.42% | 51 |
|
|
2016
Q4 | $51.4M | Sell |
357,846
-1,417
| -0.4% | -$190K | 0.4% | 57 |
|
|
2016
Q3 | $45M | Buy |
359,263
+20,871
| +6% | +$2.69M | 0.38% | 71 |
|
|
2016
Q2 | $44.4M | Sell |
338,392
-101,618
| -23% | -$13.9M | 0.38% | 70 |
|
|
2016
Q1 | $61.2M | Sell |
440,010
-24,346
| -5% | -$3.25M | 0.55% | 39 |
|
|
2015
Q4 | $64.8M | Sell |
464,356
-475
| -0.1% | -$65.4K | 0.59% | 38 |
|
|
2015
Q3 | $65.1M | Buy |
464,831
+33,548
| +8% | +$5.04M | 0.63% | 25 |
|
|
2015
Q2 | $70.8M | Buy |
431,283
+7,036
| +2% | +$1.12M | 0.66% | 21 |
|
|
2015
Q1 | $65.5M | Buy |
424,247
+69,156
| +19% | +$9.85M | 0.6% | 31 |
|
|
2014
Q4 | $44.6M | Buy |
355,091
+111,336
| +46% | +$13.8M | 0.41% | 70 |
|
|
2014
Q3 | $29.2M | Sell |
243,755
-115,874
| -32% | -$13.3M | 0.35% | 83 |
|
|
2014
Q2 | $38.7M | Buy |
359,629
+6,835
| +2% | +$704K | 0.37% | 73 |
|
|
2014
Q1 | $35.1M | Buy |
352,794
+3,769
| +1% | +$341K | 0.38% | 69 |
|
|
2013
Q4 | $32.2M | Buy |
349,025
+540
| +0.2% | +$48K | 0.36% | 78 |
|
|
2013
Q3 | $29.1M | Buy |
348,485
+329,080
| +1,696% | +$28.2M | 0.36% | 73 |
|
|
2013
Q2 | $1.59M | Buy |
+19,405
| New | +$1.45M | 0.02% | 517 |
|
Other funds holding ELV
VCM
VPM
Los Angeles Capital Management's ELV Position: Q1 2026 in Review
Los Angeles Capital Management increased its Elevance Health (ELV) stake by 1,898% in Q1 2026, buying an estimated $7.49M and bringing the position to 24,000 shares worth $7.03M. The position accounts for 0.03% of the portfolio, ranked #290.
Los Angeles Capital Management first reported a position in ELV in Q2 2013 and has held it in 52 quarters since. The position peaked at $91.9M in Q1 2021. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Los Angeles Capital Management held 24,000 shares of Elevance Health worth $7.03M as of Q1 2026.
- Los Angeles Capital Management bought 22,799 Elevance Health shares in Q1 2026, an estimated $7.49M.
- Elevance Health made up 0.03% of Los Angeles Capital Management's portfolio in Q1 2026, its #290 holding.
- Los Angeles Capital Management first reported a position in Elevance Health in Q2 2013 and has held it in 52 quarters since.
- Los Angeles Capital Management's Elevance Health position peaked at $91.9M in Q1 2021.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Los Angeles Capital Management's 13F filing for Q1 2026, filed 8 May 2026.